Mucosal immunization is considered the most effective means to develop a UTI vaccine and we have shown previously that intranasal immunization with MR/P fimbria is effective in protecting mice against UTI caused by Proteus mirabilis, an agent of complicated UTI [44]. Here, NR3C2 is linked to bacterial urinary tract infection.